| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 210 | 5.108 | 17.083 | 14.070 | 26.264 | 31.282 | 41.545 |
| Total Income - EUR | - | - | - | 210 | 5.108 | 17.083 | 14.070 | 26.264 | 31.282 | 41.545 |
| Total Expenses - EUR | - | - | - | 0 | 3.542 | 12.909 | 11.169 | 21.648 | 22.083 | 24.798 |
| Gross Profit/Loss - EUR | - | - | - | 210 | 1.566 | 4.174 | 2.902 | 4.616 | 9.198 | 16.746 |
| Net Profit/Loss - EUR | - | - | - | 203 | 1.468 | 4.017 | 2.761 | 4.353 | 8.885 | 16.332 |
| Employees | - | - | - | 0 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Adymedplus Ortocomfort S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 190 | 0 | 0 | 0 | 0 | 0 | 882 |
| Current Assets | - | - | - | 62 | 2.490 | 6.466 | 10.004 | 5.433 | 14.437 | 16.482 |
| Inventories | - | - | - | 0 | 0 | 210 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 955 | 529 | 3.381 | 2.671 | 856 | 1.663 |
| Cash | - | - | - | 62 | 1.535 | 5.728 | 6.623 | 2.762 | 13.581 | 14.819 |
| Shareholders Funds | - | - | - | 246 | 1.709 | 5.693 | 2.809 | 4.402 | 13.274 | 48 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 6 | 782 | 773 | 7.194 | 1.032 | 1.163 | 17.316 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Adymedplus Ortocomfort S.r.l.